Browsing Tag
Torrent Pharmaceuticals
13 posts
Torrent Pharma (NSE: TORNTPHARM) enters GLP-1 market with Sembolic and Semalix as over 40 rivals chase semaglutide patent expiry windfall
Torrent Pharmaceuticals launches India's first generic oral semaglutide alongside injectable Sembolic as GLP-1 patent expires. What the pricing and strategy mean. Read more.
Why paediatric therapies could be Jagsonpal Pharmaceuticals’ next big growth driver in FY26
Jagsonpal Pharmaceuticals is scaling paediatric therapies, aiming to capture gut health, cough, and anti-diarrhoeal demand as child healthcare awareness rises in India.
Torrent Pharmaceuticals to acquire J. B. Chemicals from KKR in INR 25,689 Cr deal: M&A to strengthen CDMO, IPM presence
Torrent Pharmaceuticals to acquire JB Pharma from KKR in INR 25,689 crore deal, followed by merger; aims to expand CDMO and India chronic segment leadership.
Torrent Pharmaceuticals strengthens diabetes care portfolio with acquisition of anti-diabetes brands
Torrent Pharmaceuticals Limited, a leader in the global pharmaceutical industry, has furthered its diabetes care portfolio with a…
Torrent Pharmaceuticals denies counterfeit allegations around Shelcal 500
Torrent Pharmaceuticals Limited, one of India’s leading pharmaceutical companies, has strongly refuted claims surrounding the quality of its…
Torrent Pharmaceuticals licenses Vonoprazan from Takeda to treat GERD in India
Torrent Pharmaceuticals Limited has secured a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company Limited to commercialize Vonoprazan,…
Torrent Pharmaceuticals to co-market Saroglitazar Mg with Zydus for liver health
Torrent Pharmaceuticals Limited and Zydus Lifesciences Limited announced a significant licensing and supply agreement to co-market Saroglitazar Mg,…
Torrent Pharmaceuticals Q1 FY24 snapshot: 10% surge in revenue amid resilient Germany performance
Torrent Pharmaceuticals, a key player in the pharmaceutical landscape, has publicized its financial figures for Q1 FY24, showcasing…
Torrent Pharmaceuticals completes ₹2,000 crore Curatio Healthcare acquisition to expand India’s cosmetic dermatology portfolio
Torrent Pharmaceuticals completes ₹2,000 crore acquisition of Curatio Healthcare, adding 50+ cosmetic dermatology brands and 600 MRs to boost growth.
Torrent Pharmaceuticals to acquire dermatology company Curatio Healthcare for Rs 20bn
Indian pharma company Torrent Pharmaceuticals has agreed to acquire cosmetic dermatology company Curatio Healthcare (I) Private Limited for…